Fortress Biotech (FBIO) Treasury Shares (2020)

Fortress Biotech's Treasury Shares history runs 13 years deep, the most recent figure standing at $3.8 million for Q4 2025.

• In Q4 2025, Treasury Shares fell 12.98% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (down 12.98% YoY), while the FY2025 annual figure was $3.8 million, down 12.98% from the prior year.
• Treasury Shares for Q1 2020 stood at $70000.0.
• The five-year high for Treasury Shares was $23.0 million in Q1 2023, with the low at $1.4 million in Q4 2022.
• The 5-year median for Treasury Shares is $5.6 million (2025), against an average of $10.7 million.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares sank 92.83% in 2023, then surged 208.86% in 2025.
• Fortress Biotech's Treasury Shares stood at $18.1 million in 2021, then plunged by 92.41% to $1.4 million in 2022, then surged by 50.86% to $2.1 million in 2023, then soared by 113.6% to $4.4 million in 2024, then retreated by 12.98% to $3.8 million in 2025.
• Business Quant data shows FBIO's Treasury Shares at $3.8 million in Q4 2025, $5.1 million in Q3 2025, and $5.7 million in Q2 2025.